Breast cancer: demographic characteristics and clinico-pathological presentation of patients in Iraq

Alwan, N.A.S.
November 2010
Eastern Mediterranean Health Journal;Nov2010, Vol. 16 Issue 11, p1159
Academic Journal
Breast cancer is the commonest type of malignancy in Iraq. The study was carried out on 721 out of a total of 5044 patients (14.3%) presenting with palpable breast lumps that were diagnosed as cancer. Approximately one third of the breast cancer patients were diagnosed at age 40-49 years; 71.9% came from urban areas; and 75% were married. History of lactation was reported in 63.1% and hormonal therapy in 29%. Positive family history was recorded in 16.2%. Although the lump was detected by the patient herself in 90.6% of cases, only 32% sought medical advice within the first month. Accordingly, 47% of these patients presented in advanced stages (III and IV). The main histological type was invasive ductal carcinoma, in which pathological changes of grade II and III were observed in 56.6% and 39.9% respectively. DNA analysis showed that 80.3% of the carcinomas were aneuploid. The findings of this study justify increasing efforts for establishing comprehensive breast cancer control programmes in Iraq.


Related Articles

  • Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Li, Q; Yao, Y; Eades, G; Liu, Z; Zhang, Y; Zhou, Q // Oncogene;5/15/2014, Vol. 33 Issue 20, p2589 

    The major goal of breast cancer prevention is to reduce the incidence of ductal carcinoma in situ (DCIS), an early stage of breast cancer. However, the biology behind DCIS formation is not well understood. It is suspected that cancer stem cells (CSCs) are already programmed in pre-malignant DCIS...

  • Ductal Carcinoma in Situ Treatment Requires a Multidisciplinary Approach. Constantinou, Chloe; Fentiman, Ian S. // Journal of Cancer Therapy;Sep2013, Vol. 4 Issue 7, p1203 

    Correct diagnosis and treatment are crucial for DCIS because it is a direct precursor of potentially lethal invasive breast cancer (IBC). As a result of mammographic screening, the incidence of DCIS rose from 1.87% per 100,000 women from 1973-1975 to 32.5% per 100,000 in 2005. The incidence of...

  • Does ductal lavage assert its role as a noninvasive diagnostic modality to identify women at low risk of breast cancer development? Konstandiadou, Ioanna; Mastoraki, Aikaterini; Kotsilianou, Olympia; Karakitsos, Petros; Athanasas, George; Smyrniotis, Vasilios; Arkadopoulos, Nikolaos // Journal of Gynecologic Oncology;Jun2012, Vol. 23 Issue 2, p110 

    Objective: Ductal lavage (DL) involves evaluation of the ductal system of the breast for detection of intra-ductal carcinomas and precursor lesions by collecting breast epithelial cells using a small-gauge catheter inserted into a ductal orifice on the nipple. The aim of this survey was to...

  • Breast Cancer in Saudi Arabia: A Review. Al-daihan, Sooad; Shafi, Ramesa // International Journal of Biotechnology & Biochemistry;2012, Vol. 8 Issue 1, p71 

    In Women, Ductal carcinoma accounts for about 85% to 90% of the breast cancers worldwide and has high prevalence in areas of Europe, northern America, Australia, New Zealand, and in southern countries of South America. Africa, Asia and the largest parts of Central and South America have rather...

  • Combined RB and PTEN Loss Identifies DCIS Primed for Invasive Breast Cancer.  // JNCI: Journal of the National Cancer Institute;Dec2012, Vol. 104 Issue 23, pNP 

    The article discusses research on combined loss of tumor suppressor genes, namely retinoblastoma (rB) and phosphatase and tensin homolog (PteN). It references a study by Agnieszka Witkiewicz and colleagues, published in the November 28, 2012 issue of the "Journal of the National Cancer...

  • Retinoblastoma and Phosphate and Tensin Homolog Tumor Suppressors: Impact on Ductal Carcinoma In Situ Progression. Knudsen, Erik S.; Pajak, Thomas F.; Qeenan, Maria; McClendon, A. Kathleen; Armon, Benjamin D.; Schwartz, Gordon F.; Witkiewicz, Agnieszka K. // JNCI: Journal of the National Cancer Institute;Dec2012, Vol. 104 Issue 23, p1825 

    Background A subset of patients with ductal carcinoma in situ (DCIS) will progress to invasive breast cancer. However, there are currently no markers to differentiate women at high risk from those at lower risk of developing invasive disease. Methods The association of two major tumor suppressor...

  • Microcalcificaciones mamarias: revisión de los descriptores y categorías BI-RADS. Arancibia H., Patricia; Taub E., Teresa; de Grazia K., José A.; Díaz C., M. Lorena; López P., Alejandra; Sáez T., Carla; Cermenati B., Tomás // Revista Chilena de Obstetricia y Ginecología;oct/nov2013, Vol. 78 Issue 5, p383 

    Breast calcifications are frequent findings on mammography. Most of them are caused by benign pathologies, although some specific grouped patterns may be caused by malignancy, especially ductal carcinoma in situ. The aim of this article is to review the BI-RADS descriptors and categories of...

  • CLINICO-EPIDEMIOLOGICAL PROFILE OF FEMALE BREAST CANCERS AND ITS IMPORTANT CORRELATES: A HOSPITAL BASED STUDY. Agrawal, Kapil H.; Rajderkar, S. S. // National Journal of Community Medicine;Apr-Jun2012, Vol. 3 Issue 2, p316 

    Background: Breast cancer is second most frequent cancers in females in India. Public health prevention measures requires an understanding of burden of disease and its epidemiology including risk factors. Aims: To study the clinico-epidemiological profile of breast cancer by conducting a...

  • Genetic risk variants associated with in situ breast cancer. Campa, Daniele; Barrdahl, Myrto; Gaude, Mia M.; Black, Amanda; Chanock, Stephen J.; Diver, W. Ryan; Gapstur, Susan M.; Haiman, Christopher; Hankinson, Susan; Hazra, Aditi; Henderson, Brian; Hoover, Robert N.; Hunter, David J.; Joshi, Amit D.; Kraft, Peter; Marchand, Loic Le; Lindström, Sara; Willett, Walter; Travis, Ruth C.; Amiano, Pilar // Breast Cancer Research;Jul2015, Vol. 17 Issue 1, p1 

    Introduction: Breast cancer in situ (BCIS) diagnoses, a precursor lesion for invasive breast cancer, comprise about 20 % of all breast cancers (BC) in countries with screening programs. Family history of BC is considered one of the strongest risk factors for BCIS. Methods: To evaluate the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics